Kodiak Sciences (KOD) Other Non Operating Income (2017 - 2026)
Kodiak Sciences (KOD) posted Other Non Operating Income of -$22000.0 for Q1 2026, up 45.0% on a QoQ basis from -$40000.0 in Q4 2025, and down 320.0% year-over-year from $10000.0 in Q1 2025.
Kodiak Sciences (KOD) Other Non Operating Income (2017 - 2026) Analysis & Trends
Kodiak Sciences' Other Non Operating Income history runs 10 years deep, the most recent figure standing at -$22000.0 for Q1 2026.
- Quarterly Other Non Operating Income fell 320.0% year-over-year to -$22000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$128000.0 (up 19.5% YoY) and the FY2025 annual result came in at -$96000.0, up 81.03% from the prior year.
- Other Non Operating Income was -$22000.0 for Q1 2026 at Kodiak Sciences, up from -$40000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $605000.0 in Q4 2022 and bottomed at -$337000.0 in Q1 2024.
- A 5-year average of -$647.06 and a median of -$38000.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income jumped 1807.69% — and 2026, when it tumbled 320.0%.
- Kodiak Sciences' Other Non Operating Income stood at $605000.0 in 2022, then tumbled by 106.45% to -$39000.0 in 2023, then tumbled by 43.59% to -$56000.0 in 2024, then climbed by 28.57% to -$40000.0 in 2025, then soared by 45.0% to -$22000.0 in 2026.
- Business Quant data shows KOD's Other Non Operating Income at -$22000.0 in Q1 2026, -$40000.0 in Q4 2025, and -$22000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,000.00 |
| Dec 31, 2025 | -40,000.00 |
| Sep 30, 2025 | -22,000.00 |
| Jun 30, 2025 | -44,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | -56,000.00 |
| Sep 30, 2024 | -25,000.00 |
| Jun 30, 2024 | -88,000.00 |
| Mar 31, 2024 | -337,000.00 |
| Dec 31, 2023 | -39,000.00 |
| Sep 30, 2023 | -38,000.00 |
| Jun 30, 2023 | -35,000.00 |
| Mar 31, 2023 | 222,000.00 |
| Dec 31, 2022 | 605,000.00 |
| Sep 30, 2022 | -40,000.00 |
| Jun 30, 2022 | -49,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Dec 31, 2021 | -114,000.00 |
| Sep 30, 2021 | -25,000.00 |
| Jun 30, 2021 | -19,000.00 |